Clarametyx Biosciences Reports Advancements in CMTX-101 Antibody Therapy for Cystic Fibrosis Infections
Clarametyx Biosciences Moves Forward with Phase 2a Study of CMTX-101 for Cystic Fibrosis Infections Clarametyx Biosciences, Inc. has successfully completed the Phase 1b portion of its clinical trial for CMTX-101,…
ModMed Unveils Cutting-Edge Solutions for Ophthalmology Practices at AAO 2024
ModMed Empowers Ophthalmology Practices with Innovative Solutions at AAO 2024 ModMed® is excited to announce its participation in the American Academy of Ophthalmology (AAO) 2024 conference, taking place from October…
DNA Script Names Marc Montserrat CEO to Propel Long-Term Growth for Enzymatic DNA Synthesis
DNA Script Appoints Marc Montserrat as CEO, Thomas Ybert Transitions to Chief Scientific Officer DNA Script, a leader in enzymatic DNA synthesis, has appointed Marc Montserrat as its new Chief…
BenevolentAI Appoints Kenneth Mulvany as Executive Chairman
BenevolentAI benoemt Kenneth Mulvany tot uitvoerend voorzitter om AI-gestuurde geneesmiddelenontwikkeling te versnellen BenevolentAI, een toonaangevend bedrijf dat geavanceerde AI toepast voor de ontdekking en ontwikkeling van biofarmaceutische geneesmiddelen, heeft vandaag…
Kezar Life Sciences Shares Positive PORTOLA Trial Safety Review for Zetomipzomib
Kezar Life Sciences Updates on Clinical Trials for Zetomipzomib Kezar Life Sciences, Inc. (Nasdaq: KZR), a biotechnology company focused on developing innovative therapeutics for immune-mediated diseases, has provided important updates…
Peripheral Vascular Devices Market Forecast 2024-2032: Key Players Include Abbott and Medtronic
The “Peripheral Vascular Devices Market Report, Forecast by Device Type, Country and Company Analysis 2024-2032” has been added to ResearchAndMarkets.com. The global peripheral vascular devices market is projected to grow…
HeartBeam Appoints Robert Eno as CEO Ahead of U.S. Commercialization
HeartBeam Appoints Robert Eno as CEO, Focused on U.S. Commercialization Industry leader brings extensive experience in developing go-to-market strategies for breakthrough products and driving growth HeartBeam, Inc. (NASDAQ: BEAT), a…
Kezar Board Rejects Unsolicited Concentra Proposal and Implements Short-Term Stockholder Rights Plan
Kezar Life Sciences Board Unanimously Rejects Concentra’s Acquisition Proposal and Implements Limited Duration Stockholder Rights Plan Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company focused on developing novel…
Nordic Group Launches LACRIFILL® Canalicular Gel for Dry Eye at AAO 2024
Nordic Pharma Introduces LACRIFILL Canalicular Gel for Dry Eye at AAO 2024 Nordic Pharma, Inc., a subsidiary of Nordic Group B.V., is showcasing LACRIFILL Canalicular Gel, a novel therapy for…
Wisp Introduces Comprehensive Weight Care Program for Women Facing Hormonal Imbalances
Wisp Expands Menopause Solutions and Launches Weight Care Vertical for Women Wisp, the leading women’s telehealth company in the U.S. dedicated to sexual and reproductive health, has announced a significant…
GE HealthCare’s New Hospital Pulse Tile Secures First Major Academic Medical Center Customer
GE HealthCare Unveils Hospital Pulse Tile for Command Center Software GE HealthCare (Nasdaq: GEHC) has announced the launch of Hospital Pulse, a new tile within its Command Center Software Platform.…
Transcarent Chosen to Enhance Evernorth’s Comprehensive Cancer Care Experience
Evernorth and Transcarent Collaborate to Deliver Unmatched Cancer Care, Navigation, and Support Services Starting January 1, 2025 Transcarent, known as the One Place for Health and Care, has been selected…